Back to Journals » Drug Design, Development and Therapy » Volume 10
Original Research
Paclitaxel plus valproic acid versus paclitaxel alone as second- or third-line therapy for advanced gastric cancer: a randomized Phase II trial
Total article views | HTML views | PDF downloads | Totals | ||
---|---|---|---|---|---|
9,489 | Dovepress* | 8,548+ | 1,350 | 9,898 | |
PubMed Central* | 941 | 350 | 1,291 | ||
Totals | 9,489 | 1,700 | 11,189 | ||
*Since 25 July 2016 |
Total mentioned | Delicious | Others | |||
---|---|---|---|---|---|
2 | 0 | 0 | 0 | 0 | 2 |
View citations on PubMed and Google Scholar